Literature DB >> 19387550

Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery.

Y Miyata1.   

Abstract

CK2 is a ubiquitous and essential protein kinase with pleiotropic substrates and function, but it remains unclear how, when, and where CK2 activity is regulated in cells. Hsp90 is a major molecular chaperone that is required for the folding and function of its client proteins. A complex containing Hsp90 and its client protein includes co-chaperones such as steroid hormone receptor-specific FKBP52 and signaling kinase-specific Cdc37. Co-chaperones work cooperatively with Hsp90 to stabilize client proteins and to keep them in a conformation amenable to activation under appropriate conditions. In this review, critical roles of CK2 in the regulation of the Hsp90-mediated chaperone system are described. CK2 phosphorylates and modulates Hsp90 and its co-chaperones FKBP52 and Cdc37. CK2-dependent phosphorylation of Cdc37 is essential for the chaperoning function of Hsp90-Cdc37 for multiple signaling protein kinases. The tumor kinome appears to become addicted to the Hsp90-Cdc37 chaperone system, thus, targeting Hsp90, Cdc37, and CK2 is a promising strategy for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387550     DOI: 10.1007/s00018-009-9152-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  49 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

3.  ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.

Authors:  Christy R Hagan; Tarah M Regan; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

4.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

5.  Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors.

Authors:  Monika Janeczko; Maciej Masłyk; Ryszard Szyszka; Andrea Baier
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

Review 6.  Hsp90 in Cancer: Transcriptional Roles in the Nucleus.

Authors:  Stuart K Calderwood; Len Neckers
Journal:  Adv Cancer Res       Date:  2015-10-12       Impact factor: 6.242

7.  Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90.

Authors:  Edgar E Boczek; Lasse G Reefschläger; Marco Dehling; Tobias J Struller; Elisabeth Häusler; Andreas Seidl; Ville R I Kaila; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

8.  The p23 co-chaperone protein is a novel substrate of CK2 in Arabidopsis.

Authors:  Kendra Tosoni; Alex Costa; Stefania Sarno; Stefano D'Alessandro; Francesca Sparla; Lorenzo A Pinna; Michela Zottini; Maria Ruzzene
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

9.  Protein kinase CK2 accumulation in "oncophilic" cells: causes and effects.

Authors:  Maria Ruzzene; Kendra Tosoni; Sofia Zanin; Luca Cesaro; Lorenzo A Pinna
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

10.  LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung.

Authors:  Nektarios Barabutis; Vaishali Handa; Christiana Dimitropoulou; Ruslan Rafikov; Connie Snead; Sanjiv Kumar; Atul Joshi; Gagan Thangjam; David Fulton; Stephen M Black; Vijay Patel; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.